Trial Site Detail

 

Drug:
Bezuclastinib
Trial:
Expanded Access to Bezuclastinib to be Coadministered With Sunitinib for Patients With Gastrointestinal Stromal Tumors
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Recruiting

 

Yale University School of Medicine

333 Cedar St     
New Haven , CT 06510
USA

 

Principal Investigator:
Contact:
Sharon Huie sharon.huie@yale.edu
Activation Status of this Site:
Available
Notes about this Site:
Yale University School of Medicine Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.